Global Oncology Drugs Market By Drug Class (Cytotoxic Drugs, Alkylating Agents, Antimetabolites, Others) Targeted Drugs (Monoclonal Antibodies, Others, Hormonal Drugs, Others) By Therapy (Chemotherapy, Targeted Therapy, Immunotherapy) By Indication (Lung Cancer, Stomach Cancer, Colorectal Cancer, Breast Cancer, Prostate Cancer, Others) By Dosage Form (Solid, Tablets, Capsules, Liquid, Injectable, Prefilled Syringes, Others) By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033

Published date: Sep 2024
Report ID: 128549
Number of Pages:
Format:

Table of Contents
- 1. Executive Summary
  - 1.1. Definition
  - 1.2. Market Snapshot
  - 1.3. Market Overview
  - 1.4. Segment Overview
  - 1.5. Regional Overview
  - 1.6. Competitive Landscape
  - 1.7. Taxonomy
- 2. Global Market Overview
  - 2.1. Global Market Insights and Industry Overview
  - 2.2. Market Dynamics
    2.2.1. Drivers
    2.2.2. Restraints
    2.2.3. Opportunities
    2.2.4. Key Oncology Drugs Market Trends
  - 2.3. Regulatory Framework
  - 2.4. Opportunity Map Analysis
  - 2.5. Opportunity Orbits
  - 2.6. PESTLE Analysis
  - 2.7. PORTER’S Five Force Analysis
  - 2.8. Drivers & Restraints Impact Analysis
  - 2.9. Value Chain Analysis
    2.9.1. List of Raw Materials Suppliers
    2.9.2. List of Oncology Drugs Manufacturers
    2.9.3. List of Dealer/Distributors
  - 2.10. Regional Market Share and BPS Analysis
  - 2.11. Impact of Macro-economic Factors/Geopolitical Factors
- 3. Global Oncology Drugs Market Analysis and Forecast, By Segment, 2019-2033
  - 3.1. Key Findings
  - 3.2. Global Oncology Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug Class, 2019-2033
  - 3.3. Global Oncology Drugs Market Attractiveness Analysis, By Drug Class
    3.3.1. Cytotoxic Drugs
    3.3.1.1. Insights
    3.3.1.2. Key Takeaways
    3.3.2. Targeted Drugs
    3.3.2.1. Insights
    3.3.2.2. Key Takeaways
    3.3.3. Hormonal Drugs
    3.3.3.1. Insights
    3.3.3.2. Key Takeaways
    3.3.4. Others
    3.3.4.1. Insights
    3.3.4.2. Key Takeaways
  - 3.4. Global Oncology Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Therapy, 2019-2033
  - 3.5. Global Oncology Drugs Market Attractiveness Analysis, By Therapy
    3.5.1. Chemotherapy
    3.5.1.1. Insights
    3.5.1.2. Key Takeaways
    3.5.2. Targeted Therapy
    3.5.2.1. Insights
    3.5.2.2. Key Takeaways
    3.5.3. Immunotherapy
    3.5.3.1. Insights
    3.5.3.2. Key Takeaways
  - 3.6. Global Oncology Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Indication, 2019-2033
  - 3.7. Global Oncology Drugs Market Attractiveness Analysis, By Indication
    3.7.1. Lung Cancer
    3.7.1.1. Insights
    3.7.1.2. Key Takeaways
    3.7.2. Stomach Cancer
    3.7.2.1. Insights
    3.7.2.2. Key Takeaways
    3.7.3. Colorectal Cancer
    3.7.3.1. Insights
    3.7.3.2. Key Takeaways
    3.7.4. Breast Cancer
    3.7.4.1. Insights
    3.7.4.2. Key Takeaways
    3.7.5. Prostate Cancer
    3.7.5.1. Insights
    3.7.5.2. Key Takeaways
    3.7.6. Others
    3.7.6.1. Insights
    3.7.6.2. Key Takeaways
  - 3.8. Global Oncology Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Dosage Form, 2019-2033
  - 3.9. Global Oncology Drugs Market Attractiveness Analysis, By Dosage Form
    3.9.1. Solid
    3.9.1.1. Insights
    3.9.1.2. Key Takeaways
    3.9.2. Liquid
    3.9.2.1. Insights
    3.9.2.2. Key Takeaways
    3.9.3. Injectable
    3.9.3.1. Insights
    3.9.3.2. Key Takeaways
  - 3.10. Global Oncology Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2019-2033
  - 3.11. Global Oncology Drugs Market Attractiveness Analysis, By Distribution Channel
    3.11.1. Hospital Pharmacies
    3.11.1.1. Insights
    3.11.1.2. Key Takeaways
    3.11.2. Retail Pharmacies
    3.11.2.1. Insights
    3.11.2.2. Key Takeaways
    3.11.3. Online Pharmacies
    3.11.3.1. Insights
    3.11.3.2. Key Takeaways
- 4. Global Oncology Drugs Market Analysis and Forecast, By Region, 2019-2033
  - 4.1. Key Findings
  - 4.2. Global Oncology Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Region, 2019-2033
    4.2.1. North America
    4.2.1.1. Regional Insights
    4.2.2. Europe
    4.2.2.1. Regional Insights
    4.2.3. Asia Pacific
    4.2.3.1. Regional Insights
    4.2.4. Latin America
    4.2.4.1. Regional Insights
    4.2.5. Middle East & Africa
    4.2.5.1. Regional Insights
  - 4.3. Global Oncology Drugs Market Attractiveness Analysis, By Region
- 5. North America Oncology Drugs Market Analysis and Forecast, 2019-2033
  - 5.1. Key Findings
  - 5.2. North America Oncology Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug Class, 2019-2033
  - 5.3. North America Oncology Drugs Market Attractiveness Analysis, By Drug Class
  - 5.4. North America Oncology Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Therapy, 2019-2033
  - 5.5. North America Oncology Drugs Market Attractiveness Analysis, By Therapy
  - 5.6. North America Oncology Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Indication, 2019-2033
  - 5.7. North America Oncology Drugs Market Attractiveness Analysis, By Indication
  - 5.8. North America Oncology Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Dosage Form, 2019-2033
  - 5.9. North America Oncology Drugs Market Attractiveness Analysis, By Dosage Form
  - 5.10. North America Oncology Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2019-2033
  - 5.11. North America Oncology Drugs Market Attractiveness Analysis, By Distribution Channel
  - 5.12. North America Oncology Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
  - 5.13. North America Oncology Drugs Market Attractiveness Analysis, By Country
    5.13.1. The US
    5.13.2. Canada
- 6. Europe Oncology Drugs Market Analysis and Forecast, 2019-2033
  - 6.1. Key Findings
  - 6.2. Europe Oncology Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug Class, 2019-2033
  - 6.3. Europe Oncology Drugs Market Attractiveness Analysis, By Drug Class
  - 6.4. Europe Oncology Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Therapy, 2019-2033
  - 6.5. Europe Oncology Drugs Market Attractiveness Analysis, By Therapy
  - 6.6. Europe Oncology Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Indication, 2019-2033
  - 6.7. Europe Oncology Drugs Market Attractiveness Analysis, By Indication
  - 6.8. Europe Oncology Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Dosage Form, 2019-2033
  - 6.9. Europe Oncology Drugs Market Attractiveness Analysis, By Dosage Form
  - 6.10. Europe Oncology Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2019-2033
  - 6.11. Europe Oncology Drugs Market Attractiveness Analysis, By Distribution Channel
  - 6.12. Europe Oncology Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
  - 6.13. Europe Oncology Drugs Market Attractiveness Analysis, By Country
    6.13.1. Germany
    6.13.2. The UK
    6.13.3. France
    6.13.4. Spain
    6.13.5. Italy
    6.13.6. Russia
    6.13.7. Netherland
    6.13.8. Rest of Europe
- 7. Asia Pacific Oncology Drugs Market Analysis and Forecast, 2019-2033
  - 7.1. Key Findings
  - 7.2. Asia Pacific Oncology Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug Class, 2019-2033
  - 7.3. Asia Pacific Oncology Drugs Market Attractiveness Analysis, By Drug Class
  - 7.4. Asia Pacific Oncology Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Therapy, 2019-2033
  - 7.5. Asia Pacific Oncology Drugs Market Attractiveness Analysis, By Therapy
  - 7.6. Asia Pacific Oncology Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Indication, 2019-2033
  - 7.7. Asia Pacific Oncology Drugs Market Attractiveness Analysis, By Indication
  - 7.8. Asia Pacific Oncology Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Dosage Form, 2019-2033
  - 7.9. Asia Pacific Oncology Drugs Market Attractiveness Analysis, By Dosage Form
  - 7.10. Asia Pacific Oncology Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2019-2033
  - 7.11. Asia Pacific Oncology Drugs Market Attractiveness Analysis, By Distribution Channel
  - 7.12. Asia Pacific Oncology Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
  - 7.13. Asia Pacific Oncology Drugs Market Attractiveness Analysis, By Country
    7.13.1. China
    7.13.2. Japan
    7.13.3. South Korea
    7.13.4. India
    7.13.5. Australia
    7.13.6. New Zealand
    7.13.7. Singapore
    7.13.8. Thailand
    7.13.9. Vietnam
    7.13.10. Rest of Asia Pacific
- 8. Latin America Oncology Drugs Market Analysis and Forecast, 2019-2033
  - 8.1. Key Findings
  - 8.2. Latin America Oncology Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug Class, 2019-2033
  - 8.3. Latin America Oncology Drugs Market Attractiveness Analysis, By Drug Class
  - 8.4. Latin America Oncology Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Therapy, 2019-2033
  - 8.5. Latin America Oncology Drugs Market Attractiveness Analysis, By Therapy
  - 8.6. Latin America Oncology Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Indication, 2019-2033
  - 8.7. Latin America Oncology Drugs Market Attractiveness Analysis, By Indication
  - 8.8. Latin America Oncology Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Dosage Form, 2019-2033
  - 8.9. Latin America Oncology Drugs Market Attractiveness Analysis, By Dosage Form
  - 8.10. Latin America Oncology Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2019-2033
  - 8.11. Latin America Oncology Drugs Market Attractiveness Analysis, By Distribution Channel
  - 8.12. Latin America Oncology Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
  - 8.13. Latin America Oncology Drugs Market Attractiveness Analysis, By Country
    8.13.1. Brazil
    8.13.2. Mexico
    8.13.3. Rest of Latin America
- 9. Middle East & Africa Oncology Drugs Market Analysis and Forecast, 2019-2033
  - 9.1. Key Findings
  - 9.2. Middle East & Africa Oncology Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug Class, 2019-2033
  - 9.3. Middle East & Africa Oncology Drugs Market Attractiveness Analysis, By Drug Class
  - 9.4. Middle East & Africa Oncology Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Therapy, 2019-2033
  - 9.5. Middle East & Africa Oncology Drugs Market Attractiveness Analysis, By Therapy
  - 9.6. Middle East & Africa Oncology Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Indication, 2019-2033
  - 9.7. Middle East & Africa Oncology Drugs Market Attractiveness Analysis, By Indication
  - 9.8. Middle East & Africa Oncology Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Dosage Form, 2019-2033
  - 9.9. Middle East & Africa Oncology Drugs Market Attractiveness Analysis, By Dosage Form
  - 9.10. Middle East & Africa Oncology Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2019-2033
  - 9.11. Middle East & Africa Oncology Drugs Market Attractiveness Analysis, By Distribution Channel
  - 9.12. Middle East & Africa Oncology Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
  - 9.13. Middle East & Africa Oncology Drugs Market Attractiveness Analysis, By Country
    9.13.1. South Africa
    9.13.2. Saudi Arabia
    9.13.3. UAE
    9.13.4. Rest of Middle East & Africa
- 10. Competitive Landscape & Company Profiles
  - 10.1. Market Competition Scenario Analysis, By Company
    10.1.1. Key Takeaways
  - 10.2. Overview of Major Market Players
  - 10.3. Competitor Landscape
  - 10.4. Strategic Mapping
  - 10.5. Company Life Cycle Analysis
  - 10.6. Company Market Share Analysis
  - 10.7. Company Profiles
    10.7.1. F.Hoffmann -La Roche Ltd.
    10.7.1.1. Company Details
    10.7.1.2. Business Overview
    10.7.1.3. Product Portfolio
    10.7.1.4. Financial Insights
    10.7.1.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.1.6. SWOT Analysis
    10.7.1.7. Geographic Footprint
    10.7.2. Abbvie Inc.
    10.7.2.1. Company Details
    10.7.2.2. Business Overview
    10.7.2.3. Product Portfolio
    10.7.2.4. Financial Insights
    10.7.2.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.2.6. SWOT Analysis
    10.7.2.7. Geographic Footprint
    10.7.3. Novartis AG
    10.7.3.1. Company Details
    10.7.3.2. Business Overview
    10.7.3.3. Product Portfolio
    10.7.3.4. Financial Insights
    10.7.3.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.3.6. SWOT Analysis
    10.7.3.7. Geographic Footprint
    10.7.4. Pfizer Inc.
    10.7.4.1. Company Details
    10.7.4.2. Business Overview
    10.7.4.3. Product Portfolio
    10.7.4.4. Financial Insights
    10.7.4.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.4.6. SWOT Analysis
    10.7.4.7. Geographic Footprint
    10.7.5. Bristol Myers Squibb Company
    10.7.5.1. Company Details
    10.7.5.2. Business Overview
    10.7.5.3. Product Portfolio
    10.7.5.4. Financial Insights
    10.7.5.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.5.6. SWOT Analysis
    10.7.5.7. Geographic Footprint
    10.7.6. GlaxoSmithKline plc.
    10.7.6.1. Company Details
    10.7.6.2. Business Overview
    10.7.6.3. Product Portfolio
    10.7.6.4. Financial Insights
    10.7.6.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.6.6. SWOT Analysis
    10.7.6.7. Geographic Footprint
    10.7.7. Eli Lilly and Company
    10.7.7.1. Company Details
    10.7.7.2. Business Overview
    10.7.7.3. Product Portfolio
    10.7.7.4. Financial Insights
    10.7.7.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.7.6. SWOT Analysis
    10.7.7.7. Geographic Footprint
    10.7.8. AstraZeneca
    10.7.8.1. Company Details
    10.7.8.2. Business Overview
    10.7.8.3. Product Portfolio
    10.7.8.4. Financial Insights
    10.7.8.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.8.6. SWOT Analysis
    10.7.8.7. Geographic Footprint
    10.7.9. Sanofi
    10.7.9.1. Company Details
    10.7.9.2. Business Overview
    10.7.9.3. Product Portfolio
    10.7.9.4. Financial Insights
    10.7.9.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.9.6. SWOT Analysis
    10.7.9.7. Geographic Footprint
    10.7.10. Bayer AG
    10.7.10.1. Company Details
    10.7.10.2. Business Overview
    10.7.10.3. Product Portfolio
    10.7.10.4. Financial Insights
    10.7.10.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.10.6. SWOT Analysis
    10.7.10.7. Geographic Footprint
    10.7.11. Merck & Co., Inc.
    10.7.11.1. Company Details
    10.7.11.2. Business Overview
    10.7.11.3. Product Portfolio
    10.7.11.4. Financial Insights
    10.7.11.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.11.6. SWOT Analysis
    10.7.11.7. Geographic Footprint
    10.7.12. Other Key Players
    10.7.12.1. Company Details
    10.7.12.2. Business Overview
    10.7.12.3. Product Portfolio
    10.7.12.4. Financial Insights
    10.7.12.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.12.6. SWOT Analysis
    10.7.12.7. Geographic Footprint
- 11. Methodology and Data Source
  - 11.1. Methodology/Research Approach
  - 11.2. Market Size Estimation
  - 11.3. Market Breakdown and Data Triangulation
  - 11.4. Data Source
  - 11.5. Secondary Sources
  - 11.6. Primary Sources
  - 11.7. Appendix
  - 11.8. Disclaimer
List of Tables
- Table 1. Global Oncology Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 2. Global Oncology Drugs Market Value (US$ Mn), By Therapy, 2019-2033
- Table 3. Global Oncology Drugs Market Value (US$ Mn), By Indication, 2019-2033
- Table 4. Global Oncology Drugs Market Value (US$ Mn), By Dosage Form, 2019-2033
- Table 5. Global Oncology Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 6. Global Oncology Drugs Market Value (US$ Mn), By Region, 2019-2033
- Table 7. North America Oncology Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 8. North America Oncology Drugs Market Value (US$ Mn), By Therapy, 2019-2033
- Table 9. North America Oncology Drugs Market Value (US$ Mn), By Indication, 2019-2033
- Table 10. North America Oncology Drugs Market Value (US$ Mn), By Dosage Form, 2019-2033
- Table 11. North America Oncology Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 12. North America Oncology Drugs Market Value (US$ Mn), By Country, 2019-2033
- Table 13. The US Oncology Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 14. The US Oncology Drugs Market Value (US$ Mn), By Therapy, 2019-2033
- Table 15. The US Oncology Drugs Market Value (US$ Mn), By Indication, 2019-2033
- Table 16. The US Oncology Drugs Market Value (US$ Mn), By Dosage Form, 2019-2033
- Table 17. The US Oncology Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 18. Canada Oncology Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 19. Canada Oncology Drugs Market Value (US$ Mn), By Therapy, 2019-2033
- Table 20. Canada Oncology Drugs Market Value (US$ Mn), By Indication, 2019-2033
- Table 21. Canada Oncology Drugs Market Value (US$ Mn), By Dosage Form, 2019-2033
- Table 22. Canada Oncology Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 23. Europe Oncology Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 24. Europe Oncology Drugs Market Value (US$ Mn), By Therapy, 2019-2033
- Table 25. Europe Oncology Drugs Market Value (US$ Mn), By Indication, 2019-2033
- Table 26. Europe Oncology Drugs Market Value (US$ Mn), By Dosage Form, 2019-2033
- Table 27. Europe Oncology Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 28. Europe Oncology Drugs Market Value (US$ Mn), By Country, 2019-2033
- Table 29. Germany Oncology Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 30. Germany Oncology Drugs Market Value (US$ Mn), By Therapy, 2019-2033
- Table 31. Germany Oncology Drugs Market Value (US$ Mn), By Indication, 2019-2033
- Table 32. Germany Oncology Drugs Market Value (US$ Mn), By Dosage Form, 2019-2033
- Table 33. Germany Oncology Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 34. The UK Oncology Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 35. The UK Oncology Drugs Market Value (US$ Mn), By Therapy, 2019-2033
- Table 36. The UK Oncology Drugs Market Value (US$ Mn), By Indication, 2019-2033
- Table 37. The UK Oncology Drugs Market Value (US$ Mn), By Dosage Form, 2019-2033
- Table 38. The UK Oncology Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 39. France Oncology Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 40. France Oncology Drugs Market Value (US$ Mn), By Therapy, 2019-2033
- Table 41. France Oncology Drugs Market Value (US$ Mn), By Indication, 2019-2033
- Table 42. France Oncology Drugs Market Value (US$ Mn), By Dosage Form, 2019-2033
- Table 43. France Oncology Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 44. Spain Oncology Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 45. Spain Oncology Drugs Market Value (US$ Mn), By Therapy, 2019-2033
- Table 46. Spain Oncology Drugs Market Value (US$ Mn), By Indication, 2019-2033
- Table 47. Spain Oncology Drugs Market Value (US$ Mn), By Dosage Form, 2019-2033
- Table 48. Spain Oncology Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 49. Italy Oncology Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 50. Italy Oncology Drugs Market Value (US$ Mn), By Therapy, 2019-2033
- Table 51. Italy Oncology Drugs Market Value (US$ Mn), By Indication, 2019-2033
- Table 52. Italy Oncology Drugs Market Value (US$ Mn), By Dosage Form, 2019-2033
- Table 53. Italy Oncology Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 54. Russia Oncology Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 55. Russia Oncology Drugs Market Value (US$ Mn), By Therapy, 2019-2033
- Table 56. Russia Oncology Drugs Market Value (US$ Mn), By Indication, 2019-2033
- Table 57. Russia Oncology Drugs Market Value (US$ Mn), By Dosage Form, 2019-2033
- Table 58. Russia Oncology Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 59. Netherland Oncology Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 60. Netherland Oncology Drugs Market Value (US$ Mn), By Therapy, 2019-2033
- Table 61. Netherland Oncology Drugs Market Value (US$ Mn), By Indication, 2019-2033
- Table 62. Netherland Oncology Drugs Market Value (US$ Mn), By Dosage Form, 2019-2033
- Table 63. Netherland Oncology Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 64. Rest of Europe Oncology Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 65. Rest of Europe Oncology Drugs Market Value (US$ Mn), By Therapy, 2019-2033
- Table 66. Rest of Europe Oncology Drugs Market Value (US$ Mn), By Indication, 2019-2033
- Table 67. Rest of Europe Oncology Drugs Market Value (US$ Mn), By Dosage Form, 2019-2033
- Table 68. Rest of Europe Oncology Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 69. Asia Pacific Oncology Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 70. Asia Pacific Oncology Drugs Market Value (US$ Mn), By Therapy, 2019-2033
- Table 71. Asia Pacific Oncology Drugs Market Value (US$ Mn), By Indication, 2019-2033
- Table 72. Asia Pacific Oncology Drugs Market Value (US$ Mn), By Dosage Form, 2019-2033
- Table 73. Asia Pacific Oncology Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 74. Asia Pacific Oncology Drugs Market Value (US$ Mn), By Country, 2019-2033
- Table 75. China Oncology Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 76. China Oncology Drugs Market Value (US$ Mn), By Therapy, 2019-2033
- Table 77. China Oncology Drugs Market Value (US$ Mn), By Indication, 2019-2033
- Table 78. China Oncology Drugs Market Value (US$ Mn), By Dosage Form, 2019-2033
- Table 79. China Oncology Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 80. India Oncology Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 81. India Oncology Drugs Market Value (US$ Mn), By Therapy, 2019-2033
- Table 82. India Oncology Drugs Market Value (US$ Mn), By Indication, 2019-2033
- Table 83. India Oncology Drugs Market Value (US$ Mn), By Dosage Form, 2019-2033
- Table 84. India Oncology Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 85. Japan Oncology Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 86. Japan Oncology Drugs Market Value (US$ Mn), By Therapy, 2019-2033
- Table 87. Japan Oncology Drugs Market Value (US$ Mn), By Indication, 2019-2033
- Table 88. Japan Oncology Drugs Market Value (US$ Mn), By Dosage Form, 2019-2033
- Table 89. Japan Oncology Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 90. South Korea Oncology Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 91. South Korea Oncology Drugs Market Value (US$ Mn), By Therapy, 2019-2033
- Table 92. South Korea Oncology Drugs Market Value (US$ Mn), By Indication, 2019-2033
- Table 93. South Korea Oncology Drugs Market Value (US$ Mn), By Dosage Form, 2019-2033
- Table 94. South Korea Oncology Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 95. Australia Oncology Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 96. Australia Oncology Drugs Market Value (US$ Mn), By Therapy, 2019-2033
- Table 97. Australia Oncology Drugs Market Value (US$ Mn), By Indication, 2019-2033
- Table 98. Australia Oncology Drugs Market Value (US$ Mn), By Dosage Form, 2019-2033
- Table 99. Australia Oncology Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 100. New Zealand Oncology Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 101. New Zealand Oncology Drugs Market Value (US$ Mn), By Therapy, 2019-2033
- Table 102. New Zealand Oncology Drugs Market Value (US$ Mn), By Indication, 2019-2033
- Table 103. New Zealand Oncology Drugs Market Value (US$ Mn), By Dosage Form, 2019-2033
- Table 104. New Zealand Oncology Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 105. Singapore Oncology Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 106. Singapore Oncology Drugs Market Value (US$ Mn), By Therapy, 2019-2033
- Table 107. Singapore Oncology Drugs Market Value (US$ Mn), By Indication, 2019-2033
- Table 108. Singapore Oncology Drugs Market Value (US$ Mn), By Dosage Form, 2019-2033
- Table 109. Singapore Oncology Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 110. Thailand Oncology Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 111. Thailand Oncology Drugs Market Value (US$ Mn), By Therapy, 2019-2033
- Table 112. Thailand Oncology Drugs Market Value (US$ Mn), By Indication, 2019-2033
- Table 113. Thailand Oncology Drugs Market Value (US$ Mn), By Dosage Form, 2019-2033
- Table 114. Thailand Oncology Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 115. Vietnam Oncology Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 116. Vietnam Oncology Drugs Market Value (US$ Mn), By Therapy, 2019-2033
- Table 117. Vietnam Oncology Drugs Market Value (US$ Mn), By Indication, 2019-2033
- Table 118. Vietnam Oncology Drugs Market Value (US$ Mn), By Dosage Form, 2019-2033
- Table 119. Vietnam Oncology Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 120. Rest of Asia Pacific Oncology Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 121. Rest of Asia Pacific Oncology Drugs Market Value (US$ Mn), By Therapy, 2019-2033
- Table 122. Rest of Asia Pacific Oncology Drugs Market Value (US$ Mn), By Indication, 2019-2033
- Table 123. Rest of Asia Pacific Oncology Drugs Market Value (US$ Mn), By Dosage Form, 2019-2033
- Table 124. Rest of Asia Pacific Oncology Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 125. Latin America Oncology Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 126. Latin America Oncology Drugs Market Value (US$ Mn), By Therapy, 2019-2033
- Table 127. Latin America Oncology Drugs Market Value (US$ Mn), By Indication, 2019-2033
- Table 128. Latin America Oncology Drugs Market Value (US$ Mn), By Dosage Form, 2019-2033
- Table 129. Latin America Oncology Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 130. Latin America Oncology Drugs Market Value (US$ Mn), By Country, 2019-2033
- Table 131. Brazil Oncology Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 132. Brazil Oncology Drugs Market Value (US$ Mn), By Therapy, 2019-2033
- Table 133. Brazil Oncology Drugs Market Value (US$ Mn), By Indication, 2019-2033
- Table 134. Brazil Oncology Drugs Market Value (US$ Mn), By Dosage Form, 2019-2033
- Table 135. Brazil Oncology Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 136. Mexico Oncology Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 137. Mexico Oncology Drugs Market Value (US$ Mn), By Therapy, 2019-2033
- Table 138. Mexico Oncology Drugs Market Value (US$ Mn), By Indication, 2019-2033
- Table 139. Mexico Oncology Drugs Market Value (US$ Mn), By Dosage Form, 2019-2033
- Table 140. Mexico Oncology Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 141. Rest of Latin America Oncology Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 142. Rest of Latin America Oncology Drugs Market Value (US$ Mn), By Therapy, 2019-2033
- Table 143. Rest of Latin America Oncology Drugs Market Value (US$ Mn), By Indication, 2019-2033
- Table 144. Rest of Latin America Oncology Drugs Market Value (US$ Mn), By Dosage Form, 2019-2033
- Table 145. Rest of Latin America Oncology Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 146. Middle East & Africa Oncology Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 147. Middle East & Africa Oncology Drugs Market Value (US$ Mn), By Therapy, 2019-2033
- Table 148. Middle East & Africa Oncology Drugs Market Value (US$ Mn), By Indication, 2019-2033
- Table 149. Middle East & Africa Oncology Drugs Market Value (US$ Mn), By Dosage Form, 2019-2033
- Table 150. Middle East & Africa Oncology Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 151. Middle East & Africa Oncology Drugs Market Value (US$ Mn), By Country, 2019-2033
- Table 152. South Africa Oncology Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 153. South Africa Oncology Drugs Market Value (US$ Mn), By Therapy, 2019-2033
- Table 154. South Africa Oncology Drugs Market Value (US$ Mn), By Indication, 2019-2033
- Table 155. South Africa Oncology Drugs Market Value (US$ Mn), By Dosage Form, 2019-2033
- Table 156. South Africa Oncology Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 157. Saudi Arabia Oncology Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 158. Saudi Arabia Oncology Drugs Market Value (US$ Mn), By Therapy, 2019-2033
- Table 159. Saudi Arabia Oncology Drugs Market Value (US$ Mn), By Indication, 2019-2033
- Table 160. Saudi Arabia Oncology Drugs Market Value (US$ Mn), By Dosage Form, 2019-2033
- Table 161. Saudi Arabia Oncology Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 162. UAE Oncology Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 163. UAE Oncology Drugs Market Value (US$ Mn), By Therapy, 2019-2033
- Table 164. UAE Oncology Drugs Market Value (US$ Mn), By Indication, 2019-2033
- Table 165. UAE Oncology Drugs Market Value (US$ Mn), By Dosage Form, 2019-2033
- Table 166. UAE Oncology Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 167. Rest of Middle East & Africa Oncology Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 168. Rest of Middle East & Africa Oncology Drugs Market Value (US$ Mn), By Therapy, 2019-2033
- Table 169. Rest of Middle East & Africa Oncology Drugs Market Value (US$ Mn), By Indication, 2019-2033
- Table 170. Rest of Middle East & Africa Oncology Drugs Market Value (US$ Mn), By Dosage Form, 2019-2033
- Table 171. Rest of Middle East & Africa Oncology Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
List of Figures
- Figure 1. Global Oncology Drugs Market Snapshot: Market Value (US$ Mn), 2019-2033
- Figure 2. Opportunity Map
- Figure 3. Opportunity Orbit
- Figure 4. Regional Market Share and BPS Analysis in the Oncology Drugs Market
- Figure 5. Global Oncology Drugs Market Analysis, By Drug Class, 2019, 2023 and 2033
- Figure 6. Global Oncology Drugs Market Attractiveness Analysis, By Drug Class
- Figure 7. Global Oncology Drugs Market Analysis, By Therapy, 2019, 2023 and 2033
- Figure 8. Global Oncology Drugs Market Attractiveness Analysis, By Therapy
- Figure 9. Global Oncology Drugs Market Analysis, By Indication, 2019, 2023 and 2033
- Figure 10. Global Oncology Drugs Market Attractiveness Analysis, By Indication
- Figure 11. Global Oncology Drugs Market Analysis, By Dosage Form, 2019, 2023 and 2033
- Figure 12. Global Oncology Drugs Market Attractiveness Analysis, By Dosage Form
- Figure 13. Global Oncology Drugs Market Analysis, By Distribution Channel, 2019, 2023 and 2033
- Figure 14. Global Oncology Drugs Market Attractiveness Analysis, By Distribution Channel
- Figure 15. Global Oncology Drugs Market Analysis, By Region, 2019, 2023 and 2033
- Figure 16. Global Oncology Drugs Market Attractiveness Analysis, By Region
- Figure 17. North America Oncology Drugs Market Analysis, By Drug Class, 2019, 2023 and 2033
- Figure 18. North America Oncology Drugs Market Attractiveness Analysis, By Drug Class
- Figure 19. North America Oncology Drugs Market (US$ Mn), by Cytotoxic Drugs, 2019-2033
- Figure 20. North America Oncology Drugs Market (US$ Mn), by Targeted Drugs, 2019-2033
- Figure 21. North America Oncology Drugs Market (US$ Mn), by Hormonal Drugs, 2019-2033
- Figure 22. North America Oncology Drugs Market (US$ Mn), by Others, 2019-2033
- Figure 23. North America Oncology Drugs Market Analysis, By Therapy, 2019, 2023 and 2033
- Figure 24. North America Oncology Drugs Market Attractiveness Analysis, By Therapy
- Figure 25. North America Oncology Drugs Market (US$ Mn), by Chemotherapy, 2019-2033
- Figure 26. North America Oncology Drugs Market (US$ Mn), by Targeted Therapy, 2019-2033
- Figure 27. North America Oncology Drugs Market (US$ Mn), by Immunotherapy, 2019-2033
- Figure 28. North America Oncology Drugs Market Analysis, By Indication, 2019, 2023 and 2033
- Figure 29. North America Oncology Drugs Market Attractiveness Analysis, By Indication
- Figure 30. North America Oncology Drugs Market (US$ Mn), by Lung Cancer, 2019-2033
- Figure 31. North America Oncology Drugs Market (US$ Mn), by Stomach Cancer, 2019-2033
- Figure 32. North America Oncology Drugs Market (US$ Mn), by Colorectal Cancer, 2019-2033
- Figure 33. North America Oncology Drugs Market (US$ Mn), by Breast Cancer, 2019-2033
- Figure 34. North America Oncology Drugs Market (US$ Mn), by Prostate Cancer, 2019-2033
- Figure 35. North America Oncology Drugs Market (US$ Mn), by Others, 2019-2033
- Figure 36. North America Oncology Drugs Market Analysis, By Dosage Form, 2019, 2023 and 2033
- Figure 37. North America Oncology Drugs Market Attractiveness Analysis, By Dosage Form
- Figure 38. North America Oncology Drugs Market (US$ Mn), by Solid, 2019-2033
- Figure 39. North America Oncology Drugs Market (US$ Mn), by Liquid, 2019-2033
- Figure 40. North America Oncology Drugs Market (US$ Mn), by Injectable, 2019-2033
- Figure 41. North America Oncology Drugs Market Analysis, By Distribution Channel, 2019, 2023 and 2033
- Figure 42. North America Oncology Drugs Market Attractiveness Analysis, By Distribution Channel
- Figure 43. North America Oncology Drugs Market (US$ Mn), by Hospital Pharmacies, 2019-2033
- Figure 44. North America Oncology Drugs Market (US$ Mn), by Retail Pharmacies, 2019-2033
- Figure 45. North America Oncology Drugs Market (US$ Mn), by Online Pharmacies, 2019-2033
- Figure 46. North America Oncology Drugs Market Analysis, By Country, 2019, 2023 and 2033
- Figure 47. North America Oncology Drugs Market Attractiveness Analysis, By Country
- Figure 48. Europe Oncology Drugs Market Analysis, By Drug Class, 2019, 2023 and 2033
- Figure 49. Europe Oncology Drugs Market Attractiveness Analysis, By Drug Class
- Figure 50. Europe Oncology Drugs Market (US$ Mn), by Cytotoxic Drugs, 2019-2033
- Figure 51. Europe Oncology Drugs Market (US$ Mn), by Targeted Drugs, 2019-2033
- Figure 52. Europe Oncology Drugs Market (US$ Mn), by Hormonal Drugs, 2019-2033
- Figure 53. Europe Oncology Drugs Market (US$ Mn), by Others, 2019-2033
- Figure 54. Europe Oncology Drugs Market Analysis, By Therapy, 2019, 2023 and 2033
- Figure 55. Europe Oncology Drugs Market Attractiveness Analysis, By Therapy
- Figure 56. Europe Oncology Drugs Market (US$ Mn), by Chemotherapy, 2019-2033
- Figure 57. Europe Oncology Drugs Market (US$ Mn), by Targeted Therapy, 2019-2033
- Figure 58. Europe Oncology Drugs Market (US$ Mn), by Immunotherapy, 2019-2033
- Figure 59. Europe Oncology Drugs Market Analysis, By Indication, 2019, 2023 and 2033
- Figure 60. Europe Oncology Drugs Market Attractiveness Analysis, By Indication
- Figure 61. Europe Oncology Drugs Market (US$ Mn), by Lung Cancer, 2019-2033
- Figure 62. Europe Oncology Drugs Market (US$ Mn), by Stomach Cancer, 2019-2033
- Figure 63. Europe Oncology Drugs Market (US$ Mn), by Colorectal Cancer, 2019-2033
- Figure 64. Europe Oncology Drugs Market (US$ Mn), by Breast Cancer, 2019-2033
- Figure 65. Europe Oncology Drugs Market (US$ Mn), by Prostate Cancer, 2019-2033
- Figure 66. Europe Oncology Drugs Market (US$ Mn), by Others, 2019-2033
- Figure 67. Europe Oncology Drugs Market Analysis, By Dosage Form, 2019, 2023 and 2033
- Figure 68. Europe Oncology Drugs Market Attractiveness Analysis, By Dosage Form
- Figure 69. Europe Oncology Drugs Market (US$ Mn), by Solid, 2019-2033
- Figure 70. Europe Oncology Drugs Market (US$ Mn), by Liquid, 2019-2033
- Figure 71. Europe Oncology Drugs Market (US$ Mn), by Injectable, 2019-2033
- Figure 72. Europe Oncology Drugs Market Analysis, By Distribution Channel, 2019, 2023 and 2033
- Figure 73. Europe Oncology Drugs Market Attractiveness Analysis, By Distribution Channel
- Figure 74. Europe Oncology Drugs Market (US$ Mn), by Hospital Pharmacies, 2019-2033
- Figure 75. Europe Oncology Drugs Market (US$ Mn), by Retail Pharmacies, 2019-2033
- Figure 76. Europe Oncology Drugs Market (US$ Mn), by Online Pharmacies, 2019-2033
- Figure 77. Europe Oncology Drugs Market Analysis, By Country, 2019, 2023 and 2033
- Figure 78. Europe Oncology Drugs Market Attractiveness Analysis, By Country
- Figure 79. Asia Pacific Oncology Drugs Market Analysis, By Drug Class, 2019, 2023 and 2033
- Figure 80. Asia Pacific Oncology Drugs Market Attractiveness Analysis, By Drug Class
- Figure 81. Asia Pacific Oncology Drugs Market (US$ Mn), by Cytotoxic Drugs, 2019-2033
- Figure 82. Asia Pacific Oncology Drugs Market (US$ Mn), by Targeted Drugs, 2019-2033
- Figure 83. Asia Pacific Oncology Drugs Market (US$ Mn), by Hormonal Drugs, 2019-2033
- Figure 84. Asia Pacific Oncology Drugs Market (US$ Mn), by Others, 2019-2033
- Figure 85. Asia Pacific Oncology Drugs Market Analysis, By Therapy, 2019, 2023 and 2033
- Figure 86. Asia Pacific Oncology Drugs Market Attractiveness Analysis, By Therapy
- Figure 87. Asia Pacific Oncology Drugs Market (US$ Mn), by Chemotherapy, 2019-2033
- Figure 88. Asia Pacific Oncology Drugs Market (US$ Mn), by Targeted Therapy, 2019-2033
- Figure 89. Asia Pacific Oncology Drugs Market (US$ Mn), by Immunotherapy, 2019-2033
- Figure 90. Asia Pacific Oncology Drugs Market Analysis, By Indication, 2019, 2023 and 2033
- Figure 91. Asia Pacific Oncology Drugs Market Attractiveness Analysis, By Indication
- Figure 92. Asia Pacific Oncology Drugs Market (US$ Mn), by Lung Cancer, 2019-2033
- Figure 93. Asia Pacific Oncology Drugs Market (US$ Mn), by Stomach Cancer, 2019-2033
- Figure 94. Asia Pacific Oncology Drugs Market (US$ Mn), by Colorectal Cancer, 2019-2033
- Figure 95. Asia Pacific Oncology Drugs Market (US$ Mn), by Breast Cancer, 2019-2033
- Figure 96. Asia Pacific Oncology Drugs Market (US$ Mn), by Prostate Cancer, 2019-2033
- Figure 97. Asia Pacific Oncology Drugs Market (US$ Mn), by Others, 2019-2033
- Figure 98. Asia Pacific Oncology Drugs Market Analysis, By Dosage Form, 2019, 2023 and 2033
- Figure 99. Asia Pacific Oncology Drugs Market Attractiveness Analysis, By Dosage Form
- Figure 100. Asia Pacific Oncology Drugs Market (US$ Mn), by Solid, 2019-2033
- Figure 101. Asia Pacific Oncology Drugs Market (US$ Mn), by Liquid, 2019-2033
- Figure 102. Asia Pacific Oncology Drugs Market (US$ Mn), by Injectable, 2019-2033
- Figure 103. Asia Pacific Oncology Drugs Market Analysis, By Distribution Channel, 2019, 2023 and 2033
- Figure 104. Asia Pacific Oncology Drugs Market Attractiveness Analysis, By Distribution Channel
- Figure 105. Asia Pacific Oncology Drugs Market (US$ Mn), by Hospital Pharmacies, 2019-2033
- Figure 106. Asia Pacific Oncology Drugs Market (US$ Mn), by Retail Pharmacies, 2019-2033
- Figure 107. Asia Pacific Oncology Drugs Market (US$ Mn), by Online Pharmacies, 2019-2033
- Figure 108. Asia Pacific Oncology Drugs Market Analysis, By Country, 2019, 2023 and 2033
- Figure 109. Asia Pacific Oncology Drugs Market Attractiveness Analysis, By Country
- Figure 110. Latin America Oncology Drugs Market Analysis, By Drug Class, 2019, 2023 and 2033
- Figure 111. Latin America Oncology Drugs Market Attractiveness Analysis, By Drug Class
- Figure 112. Latin America Oncology Drugs Market (US$ Mn), by Cytotoxic Drugs, 2019-2033
- Figure 113. Latin America Oncology Drugs Market (US$ Mn), by Targeted Drugs, 2019-2033
- Figure 114. Latin America Oncology Drugs Market (US$ Mn), by Hormonal Drugs, 2019-2033
- Figure 115. Latin America Oncology Drugs Market (US$ Mn), by Others, 2019-2033
- Figure 116. Latin America Oncology Drugs Market Analysis, By Therapy, 2019, 2023 and 2033
- Figure 117. Latin America Oncology Drugs Market Attractiveness Analysis, By Therapy
- Figure 118. Latin America Oncology Drugs Market (US$ Mn), by Chemotherapy, 2019-2033
- Figure 119. Latin America Oncology Drugs Market (US$ Mn), by Targeted Therapy, 2019-2033
- Figure 120. Latin America Oncology Drugs Market (US$ Mn), by Immunotherapy, 2019-2033
- Figure 121. Latin America Oncology Drugs Market Analysis, By Indication, 2019, 2023 and 2033
- Figure 122. Latin America Oncology Drugs Market Attractiveness Analysis, By Indication
- Figure 123. Latin America Oncology Drugs Market (US$ Mn), by Lung Cancer, 2019-2033
- Figure 124. Latin America Oncology Drugs Market (US$ Mn), by Stomach Cancer, 2019-2033
- Figure 125. Latin America Oncology Drugs Market (US$ Mn), by Colorectal Cancer, 2019-2033
- Figure 126. Latin America Oncology Drugs Market (US$ Mn), by Breast Cancer, 2019-2033
- Figure 127. Latin America Oncology Drugs Market (US$ Mn), by Prostate Cancer, 2019-2033
- Figure 128. Latin America Oncology Drugs Market (US$ Mn), by Others, 2019-2033
- Figure 129. Latin America Oncology Drugs Market Analysis, By Dosage Form, 2019, 2023 and 2033
- Figure 130. Latin America Oncology Drugs Market Attractiveness Analysis, By Dosage Form
- Figure 131. Latin America Oncology Drugs Market (US$ Mn), by Solid, 2019-2033
- Figure 132. Latin America Oncology Drugs Market (US$ Mn), by Liquid, 2019-2033
- Figure 133. Latin America Oncology Drugs Market (US$ Mn), by Injectable, 2019-2033
- Figure 134. Latin America Oncology Drugs Market Analysis, By Distribution Channel, 2019, 2023 and 2033
- Figure 135. Latin America Oncology Drugs Market Attractiveness Analysis, By Distribution Channel
- Figure 136. Latin America Oncology Drugs Market (US$ Mn), by Hospital Pharmacies, 2019-2033
- Figure 137. Latin America Oncology Drugs Market (US$ Mn), by Retail Pharmacies, 2019-2033
- Figure 138. Latin America Oncology Drugs Market (US$ Mn), by Online Pharmacies, 2019-2033
- Figure 139. Latin America Oncology Drugs Market Analysis, By Country, 2019, 2023 and 2033
- Figure 140. Latin America Oncology Drugs Market Attractiveness Analysis, By Country
- Figure 141. Middle East and Africa Oncology Drugs Market Analysis, By Drug Class, 2019, 2023 and 2033
- Figure 142. Middle East and Africa Oncology Drugs Market Attractiveness Analysis, By Drug Class
- Figure 143. Middle East and Africa Oncology Drugs Market (US$ Mn), by Cytotoxic Drugs, 2019-2033
- Figure 144. Middle East and Africa Oncology Drugs Market (US$ Mn), by Targeted Drugs, 2019-2033
- Figure 145. Middle East and Africa Oncology Drugs Market (US$ Mn), by Hormonal Drugs, 2019-2033
- Figure 146. Middle East and Africa Oncology Drugs Market (US$ Mn), by Others, 2019-2033
- Figure 147. Middle East and Africa Oncology Drugs Market Analysis, By Therapy, 2019, 2023 and 2033
- Figure 148. Middle East and Africa Oncology Drugs Market Attractiveness Analysis, By Therapy
- Figure 149. Middle East and Africa Oncology Drugs Market (US$ Mn), by Chemotherapy, 2019-2033
- Figure 150. Middle East and Africa Oncology Drugs Market (US$ Mn), by Targeted Therapy, 2019-2033
- Figure 151. Middle East and Africa Oncology Drugs Market (US$ Mn), by Immunotherapy, 2019-2033
- Figure 152. Middle East and Africa Oncology Drugs Market Analysis, By Indication, 2019, 2023 and 2033
- Figure 153. Middle East and Africa Oncology Drugs Market Attractiveness Analysis, By Indication
- Figure 154. Middle East and Africa Oncology Drugs Market (US$ Mn), by Lung Cancer, 2019-2033
- Figure 155. Middle East and Africa Oncology Drugs Market (US$ Mn), by Stomach Cancer, 2019-2033
- Figure 156. Middle East and Africa Oncology Drugs Market (US$ Mn), by Colorectal Cancer, 2019-2033
- Figure 157. Middle East and Africa Oncology Drugs Market (US$ Mn), by Breast Cancer, 2019-2033
- Figure 158. Middle East and Africa Oncology Drugs Market (US$ Mn), by Prostate Cancer, 2019-2033
- Figure 159. Middle East and Africa Oncology Drugs Market (US$ Mn), by Others, 2019-2033
- Figure 160. Middle East and Africa Oncology Drugs Market Analysis, By Dosage Form, 2019, 2023 and 2033
- Figure 161. Middle East and Africa Oncology Drugs Market Attractiveness Analysis, By Dosage Form
- Figure 162. Middle East and Africa Oncology Drugs Market (US$ Mn), by Solid, 2019-2033
- Figure 163. Middle East and Africa Oncology Drugs Market (US$ Mn), by Liquid, 2019-2033
- Figure 164. Middle East and Africa Oncology Drugs Market (US$ Mn), by Injectable, 2019-2033
- Figure 165. Middle East and Africa Oncology Drugs Market Analysis, By Distribution Channel, 2019, 2023 and 2033
- Figure 166. Middle East and Africa Oncology Drugs Market Attractiveness Analysis, By Distribution Channel
- Figure 167. Middle East and Africa Oncology Drugs Market (US$ Mn), by Hospital Pharmacies, 2019-2033
- Figure 168. Middle East and Africa Oncology Drugs Market (US$ Mn), by Retail Pharmacies, 2019-2033
- Figure 169. Middle East and Africa Oncology Drugs Market (US$ Mn), by Online Pharmacies, 2019-2033
- Figure 170. Middle East and Africa Oncology Drugs Market Analysis, By Country, 2019, 2023 and 2033
- Figure 171. Middle East and Africa Oncology Drugs Market Attractiveness Analysis, By Country
- F.Hoffmann -La Roche Ltd.
- AbbVie Inc. Company Profile
- Novartis AG Company Profile
- Pfizer Inc Company Profile
- Bristol Myers Squibb Company Profile
- GlaxoSmithKline plc.
- Eli Lilly and Company
- AstraZeneca Plc Company Profile
- Sanofi Company Profile
- Bayer AG Company Profile
- Merck & Co., Inc.
Settings

Related Reports

Our Clients

✖

Request a Sample Report

We'll get back to you as quickly as possible

	Single User $6,000 $3,999 USD / per unit save 24%	Multi User $8,000 $5,999 USD / per unit save 28%	Corporate User $10,000 $6,999 USD / per unit save 32%
e-Access
Report Library Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization	No	up to 10 hrs work	up to 30 hrs work
Accessibility	1 User	2-5 User	Unlimited
Analyst Support	up to 20 hrs	up to 40 hrs	up to 50 hrs
Benefit	Up to 20% off on next purchase	Up to 25% off on next purchase	Up to 30% off on next purchase
	Buy Now ($ 3,999)	Buy Now ($ 5,999)	Buy Now ($ 6,999)

Table of Contents

List of Tables

List of Figures

Related Reports

Our Clients